文献速递脑血管病

女性和男性特异性卒中风险因素:系统综述与荟萃分析

Female- and Male-Specific Risk Factors for Stroke: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Neurol · 2017-01-01

女性中,妊娠期高血压疾病增加缺血性卒中风险(RR 1.80),卵巢切除术、妊娠期高血压疾病、早产和死产增加任何卒中风险;子宫切除术可能具有保护作用。男性中,雄激素剥夺治疗增加缺血性和任何卒中风险,勃起功能障碍增加任何卒中风险。考虑性别特异性风险因素可改善个体化卒中风险评估。

要点

  • 女性妊娠期高血压疾病与缺血性卒中风险升高相关(RR 1.80)。
  • 女性卵巢切除术、妊娠期高血压疾病、早产和死产增加任何卒中风险。
  • 男性雄激素剥夺治疗增加缺血性和任何卒中风险,勃起功能障碍增加任何卒中风险。

核心结论

  • 女性特异性特征增加卒中风险,包括妊娠期高血压疾病(缺血性卒中)、晚绝经和妊娠期高血压(出血性卒中)、卵巢切除术、妊娠期高血压疾病、早产和死产(任何卒中);子宫切除术可能对任何卒中具有保护作用。
  • 男性特异性特征增加卒中风险,包括药物雄激素剥夺治疗(缺血性和任何卒中)和勃起功能障碍(任何卒中)。
  • 考虑性别特异性风险因素可改善个体化卒中风险评估。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、EMBASE和文献目录,纳入1985年1月1日至2015年1月26日发表的观察性研究。
  • 采用基于方差的随机效应模型合并估计值,遵循PRISMA和MOOSE指南。

主要发现

  • 女性:任何妊娠期高血压疾病后缺血性卒中汇总相对风险为1.80(95% CI, 1.49-2.18);妊娠期高血压 vs 无妊娠期高血压疾病为1.81(95% CI, 1.44-2.27)。
  • 女性:出血性卒中汇总相对风险在绝经年龄≥55岁 vs 50-54岁为2.24(95% CI, 1.19-4.21);妊娠期高血压 vs 无妊娠期高血压为5.08(95% CI, 1.80-14.34)。
  • 女性:任何卒中汇总相对风险:卵巢切除术 vs 无卵巢切除术为1.42(95% CI, 1.34-1.50);子宫切除术 vs 无子宫切除术为0.88(95% CI, 0.85-0.90);任何妊娠期高血压疾病 vs 无为1.63(95% CI, 1.52-1.75);子痫前期或子痫 vs 无为1.54(95% CI, 1.39-1.70);妊娠期高血压 vs 无妊娠期高血压疾病为1.51(95% CI, 1.27-1.80);早产 vs 无为1.62(95% CI, 1.46-1.79);死产 vs 无妊娠并发症为1.86(95% CI, 1.15-3.02)。
  • 女性:卒中死亡汇总相对风险在妊娠期高血压 vs 无妊娠期高血压为1.57(95% CI, 1.04-2.39)。
  • 男性:缺血性卒中汇总相对风险:雄激素剥夺治疗 vs 无雄激素剥夺治疗为1.19(95% CI, 1.05-1.34);睾丸切除术 vs 无睾丸切除术为1.21(95% CI, 1.00-1.46);任何卒中汇总相对风险:雄激素剥夺治疗 vs 无为1.21(95% CI, 1.06-1.37);勃起功能障碍 vs 无为1.35(95% CI, 1.18-1.53)。

临床怎么用

  • 临床应关注女性妊娠期高血压疾病、卵巢切除术、早产和死产史,以及男性雄激素剥夺治疗和勃起功能障碍,以识别卒中高风险个体。
  • 子宫切除术可能与任何卒中风险降低相关,但需进一步研究确认。
  • 在卒中风险评估中纳入性别特异性风险因素,有助于制定个体化预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The incidence of stroke is higher in men than in women. The influence of sex-specific risk factors on stroke incidence and mortality is largely unknown. OBJECTIVE: To conduct a systematic review and meta-analysis of female- and male-specific risk factors for stroke. DATA SOURCES: PubMed, EMBASE, and the bibliographies of articles were searched for studies published between January 1, 1985, and January 26, 2015, reporting on the association between female- and male-specific characteristics and stroke. STUDY SELECTION: Observational studies reporting associations between sex-specific risk factors and stroke were selected. DATA EXTRACTION AND SYNTHESIS: Two authors performed data extraction independently. Estimates were pooled with a generic variance-based, random-effects method. We followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) recommendations. In addition, our study adhered to the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. MAIN OUTCOMES AND MEASURES: Ischemic stroke, hemorrhagic stroke, any stroke, and stroke mortality. RESULTS: This systematic review and meta-analysis included 78 studies (70 longitudinal and 8 case-control) comprising 10 187 540 persons. In women, the pooled relative risks of ischemic stroke were 1.80 (95% CI, 1.49-2.18) after any hypertensive disorder in pregnancy (HDP) (gestational hypertension [GH], preeclampsia, or eclampsia) and 1.81 (95% CI, 1.44-2.27) after GH vs no HDP. The pooled relative risks of hemorrhagic stroke were 2.24 (95% CI, 1.19-4.21) in women with menopause at the age of at least 55 years vs 50 to 54 years and 5.08 (95% CI, 1.80-14.34) after GH vs no GH. The pooled relative risks of any stroke were 1.42 (95% CI, 1.34-1.50) after oophorectomy vs no oophorectomy, 0.88 (95% CI, 0.85-0.90) after hysterectomy vs no hysterectomy, 1.63 (95% CI, 1.52-1.75) after any vs no HDP, 1.54 (95% CI, 1.39-1.70) after preeclampsia or eclampsia, 1.51 (95% CI, 1.27-1.80) after GH vs no HDP, 1.62 (95% CI, 1.46-1.79) after preterm delivery, and 1.86 (95% CI, 1.15-3.02) after stillbirth vs no pregnancy complications. The pooled relative risk of stroke mortality was 1.57 (95% CI, 1.04-2.39) after GH vs no GH. In men, the pooled relative risks of ischemic stroke were 1.19 (95% CI, 1.05-1.34) after androgen deprivation therapy (ADT) vs no ADT and 1.21 (95% CI, 1.00-1.46) after orchiectomy vs no orchiectomy. The pooled relative risks of any stroke were 1.21 (95% CI, 1.06-1.37) for ADT vs no ADT and 1.35 (95% CI, 1.18-1.53) for erectile dysfunction vs no dysfunction. CONCLUSIONS AND RELEVANCE: Female-specific characteristics increasing stroke risk include HDP for ischemic stroke, late menopause and gestational hypertension for hemorrhagic stroke, and oophorectomy, HDP, preterm delivery, and stillbirth for any stroke. Hysterectomy is possibly protective against any stroke. Male-specific characteristics increasing stroke risk include medical androgen deprivation therapy for ischemic and any stroke and erectile dysfunction for any stroke. Consideration of sex-specific risk factors can improve individualized stroke risk assessment.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Poorthuis MH, Algra AM, Algra A, et al. Female- and Male-Specific Risk Factors for Stroke: A Systematic Review and Meta-analysis. JAMA Neurol. 2017. PMID: 27842176. doi:10.1001/jamaneurol.2016.3482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。